Overview
Marcaine Use in Laparoscopic Gynecological Surgery
Status:
Terminated
Terminated
Trial end date:
2017-01-01
2017-01-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this trial is to compare incisional pain in patients receiving pre-incisional versus post operative Marcaine injection.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Weill Medical College of Cornell UniversityTreatments:
Bupivacaine
Criteria
Inclusion Criteria:- • Ages 18-50
- BMI 20-35
- Gynecologic ambulatory cases only
- Total of 3 incisions, with left and right incisions both being 5mm-10mm in size
- Not taking pain medications prior to surgery
- Length of surgery up to 3 hours
- PACU stay up to 6 hours
- Willing and able to sign informed consent
Exclusion Criteria:
- • Age or BMI out of range
- Surgery longer than 3 hours or PACU stay longer than 6 hours
- patients with chronic pelvic pain
- Oncologic cases
- Pregnant patients